Provided by Tiger Trade Technology Pte. Ltd.

Insulet

228.17
-0.4600-0.20%
Volume:212.87K
Turnover:48.57M
Market Cap:16.05B
PE:65.58
High:230.25
Open:227.68
Low:226.51
Close:228.63
52wk High:354.88
52wk Low:216.49
Shares:70.35M
Float Shares:70.08M
Volume Ratio:0.36
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.48
EPS(LYR):3.48
ROE:18.12%
ROA:9.43%
PB:10.59
PE(LYR):65.58

Loading ...

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

THOMSON REUTERS
·
Nov 21, 2025

Insulet Shares Rise After UBS Upgrade

MT Newswires Live
·
Nov 20, 2025

Top Calls on Wall Street: Nvidia, Netflix, Microsoft, DoorDash, MP Materials and More

Tiger Newspress
·
Nov 19, 2025

Insulet Corp : UBS Raises to Buy From Neutral

THOMSON REUTERS
·
Nov 19, 2025

Insulet Raised to Buy From Neutral by UBS

Dow Jones
·
Nov 19, 2025

UBS Upgrades Insulet to Buy From Neutral

MT Newswires Live
·
Nov 19, 2025

Insulet’s Strong Growth Potential and Competitive Edge Drive Buy Rating

TIPRANKS
·
Nov 19, 2025

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 19, 2025

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Nov 18, 2025

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations

GlobeNewswire
·
Nov 14, 2025

Insulet Price Target Maintained With a $370.00/Share by BTIG

Dow Jones
·
Nov 13, 2025

Insulet’s Strategic Growth and Innovation Drive Buy Rating

TIPRANKS
·
Nov 12, 2025

Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 12, 2025

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and Insulet (PODD)

TIPRANKS
·
Nov 10, 2025

Insulet price target raised to $390 from $365 at Truist

TIPRANKS
·
Nov 09, 2025

Insulet Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Nov 08, 2025

Bernstein Adjusts Insulet Price Target to $410 From $400

MT Newswires Live
·
Nov 08, 2025

Insulet (PODD) Receives a Buy from Truist Financial

TIPRANKS
·
Nov 07, 2025

Insulet price target raised to $355 from $320 at UBS

TIPRANKS
·
Nov 07, 2025

Canaccord Genuity Adjusts Price Target on Insulet to $428 From $399, Maintains Buy Rating

MT Newswires Live
·
Nov 07, 2025